Psoriatic Arthritis

Latest News

UCB Announces Head-to-Head Trial Comparing Bimekizumab and Risankizumab
UCB Announces Head-to-Head Trial Comparing Bimekizumab and Risankizumab

October 2nd 2024

This marks the first head-to-head trial of an IL-17A/F inhibitor against an IL-23 inhibitor in psoriatic arthritis treatment.

FDA Approves UCB's Bimekizumab-bkzx for Psoriatic Arthritis
FDA Approves UCB's Bimekizumab-bkzx for Psoriatic Arthritis

September 23rd 2024

Understanding the Patient and Advocate Experience: Psoriatic Disease and Skin of Color
Understanding the Patient and Advocate Experience: Psoriatic Disease and Skin of Color

August 13th 2024

Insights into Bimekizumab 2-Year Data for PsA, nr-asSpA, and AS
Insights into Bimekizumab 2-Year Data for PsA, nr-asSpA, and AS

July 24th 2024

FDA Approves Biosimilar Ustekinumab-ttwe for All Indications of Reference Medicine
FDA Approves Biosimilar Ustekinumab-ttwe for All Indications of Reference Medicine

July 1st 2024

Latest CME Events & Activities

Community Practice Connections™: 19th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

View More

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

October 16, 2024

Register Now!

Expert Illustrations & Commentaries™: A Deeper Look at the Pathogenesis of Hidradenitis Suppurativa (HS)

View More

Cancer Summaries and Commentaries™: Clinical Updates in Melanoma from Philadelphia

View More

Dermalorian™ Webinar Series on Moderate to Severe Atopic Dermatitis

November 21, 2024 - December 5, 2024

View More

21st Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

February 8, 2025

View More

Expert Illustrations & Commentaries™: Picturing the Potential Role of OX40 and OX40L Inhibitors in Atopic Dermatitis

View More

Hidradenitis Suppurativa (HS): Deepening Foundations of Knowledge in Disease Pathogenesis, Disease Severity Assessment, and Treatment Decision-Making

View More

Clinical Consultations™: Optimizing Treatment Outcomes for Patients with Generalized Pustular Psoriasis

View More

Cases and Conversations™: Applying Practice Techniques to Optimize Diagnosis and Treatment Strategies in Generalized Pustular Psoriasis

View More

Advances in™ Atopic Dermatitis: Addressing Unmet Needs in Patients With Skin of Color

View More

Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach

View More

More News

© 2024 MJH Life Sciences

All rights reserved.